{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["AAC(6\u2032)-Ib-cr", "PMQR", "QnrS", "inhibitor", "palmatine", "plasmid-mediated quinolone resistance"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "32210589", "DateRevised": {"Year": "2022", "Month": "04", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "03", "Day": "09"}], "Language": ["eng"], "ELocationID": ["10.2147/IDR.S242304"], "Journal": {"ISSN": "1178-6973", "JournalIssue": {"Volume": "13", "PubDate": {"Year": "2020"}}, "Title": "Infection and drug resistance", "ISOAbbreviation": "Infect Drug Resist"}, "ArticleTitle": "Palmatine Is a Plasmid-Mediated Quinolone Resistance (PMQR) Inhibitor That Restores the Activity of Ciprofloxacin Against QnrS and AAC(6')-Ib-cr-Producing <i>Escherichia coli</i>.", "Pagination": {"StartPage": "749", "EndPage": "759", "MedlinePgn": "749-759"}, "Abstract": {"AbstractText": ["The emergence of plasmid-mediated quinolone resistance (PMQR) is a global challenge in the treatment of clinical disease in both humans and animals and is exacerbated by the presence of different PMQR genes existing in the same bacterial strain. Here, we discovered that a natural isoquinoline alkaloid palmatine extracted from traditional Chinese medicinal plants effectively inhibited the activity of PMQR proteins QnrS and AAC(6')-Ib-cr.", "In total 120 clinical ciprofloxacin-resistant <i>Escherichia coli</i> (<i>E. coli</i>) were screened for the presence of <i>qnrS</i> and <i>aac(6')-Ib-cr</i> by PCR. Recombinant <i>E. coli</i> that produced QnrS or AAC(6')-Ib-cr proteins were constructed and the correct expression was confirmed by MALDI/TOF MS analysis and SDS-PAGE. A minimal inhibitory concentration (MICs) assay, growth curve assay and time-kill assay were conducted to evaluate the in vitro antibacterial activity of palmatine and the combination of palmatine and ciprofloxacin. Cytotoxicity assays and mouse thigh infection model were used to evaluate the in vivo synergies. Molecular docking, gyrase supercoiling assay and acetylation assay were used to clarify the mechanism of action.", "Palmatine effectively restored the activity of ciprofloxacin against <i>qnrS</i> and <i>aac(6')-Ib-cr</i>-positive <i>E. coli</i> strains in a synergistic manner in vitro. In addition, the combined therapy significantly reduced the bacterial burden in a mouse thigh infection model. Molecular docking revealed that palmatine bound at the functional large loop B of QnrS and Trp102Arg and Asp179Tyr in the binding pocket of AAC(6')-Ib-cr. Furthermore, interaction analysis confirmed that palmatine reduced the gyrase protective effect of QnrS and the acetylation effect of AAC(6')-Ib-cr.", "Our findings suggest that palmatine is a potential efficacious compound to restore PMQR-mediated ciprofloxacin resistance and warrants further preclinical evaluations."], "CopyrightInformation": "\u00a9 2020 Wang et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Agricultural Bio-Pharmaceutical Laboratory, Qingdao Agricultural University, Qingdao 266109, People's Republic of China."}], "LastName": "Wang", "ForeName": "Peng", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Agricultural Bio-Pharmaceutical Laboratory, Qingdao Agricultural University, Qingdao 266109, People's Republic of China."}], "LastName": "Hu", "ForeName": "Longfei", "Initials": "L"}, {"Identifier": ["0000-0002-7282-2340"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Centre for Veterinary Drug Safety Evaluation, College of Veterinary Medicine, China Agricultural University, Beijing 100089, People's Republic of China."}], "LastName": "Hao", "ForeName": "Zhihui", "Initials": "Z"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "Infect Drug Resist", "NlmUniqueID": "101550216", "ISSNLinking": "1178-6973"}, "CoiStatement": "The authors report no conflicts of interest in this work."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Correia S, Poeta P, H\u00e9braud M, Capelo JL, Igrejas G. Mechanisms of quinolone action and resistance: where do we stand? J Med Microbiol. 2017;66(5):551\u2013559. doi:10.1099/jmm.0.000475", "ArticleIdList": ["10.1099/jmm.0.000475", "28504927"]}, {"Citation": "Hooper DC, Jacoby GA. Topoisomerase inhibitors: fluoroquinolone mechanisms of action and resistance. Cold Spring Harb Perspect Med. 2016;6(9):a025320. doi:10.1101/cshperspect.a025320", "ArticleIdList": ["10.1101/cshperspect.a025320", "PMC5008060", "27449972"]}, {"Citation": "Kim ES, Hooper DC. Clinical importance and epidemiology of quinolone resistance. Infect Chemother. 2014;46(4):226\u2013238. doi:10.3947/ic.2014.46.4.226", "ArticleIdList": ["10.3947/ic.2014.46.4.226", "PMC4285002", "25566402"]}, {"Citation": "Xiong X, Bromley EH, Oelschlaeger P, Woolfson DN, Spencer J. Structural insights into quinolone antibiotic resistance mediated by pentapeptide repeat proteins: conserved surface loops direct the activity of a Qnr protein from a gram-negative bacterium. Nucleic Acids Res. 2011;39(9):3917\u20133927. doi:10.1093/nar/gkq1296", "ArticleIdList": ["10.1093/nar/gkq1296", "PMC3089455", "21227918"]}, {"Citation": "Yassine I, Rafei R, Osman M, Mallat H, Dabboussi F, Hamze M. Plasmid-mediated quinolone resistance: mechanisms, detection, and epidemiology in the Arab countries. Infect Genet Evol. 2019;76:104020. doi:10.1016/j.meegid.2019.104020", "ArticleIdList": ["10.1016/j.meegid.2019.104020", "31493557"]}, {"Citation": "Hooper DC, Jacoby GA. Mechanisms of drug resistance: quinolone resistance. Ann N Y Acad Sci. 2015;1354(1):12\u201331. doi:10.1111/nyas.12830", "ArticleIdList": ["10.1111/nyas.12830", "PMC4626314", "26190223"]}, {"Citation": "Aldred KJ, Kerns RJ, Osheroff N. Mechanism of quinolone action and resistance. Biochemistry. 2014;53(10):1565\u20131574. doi:10.1021/bi5000564", "ArticleIdList": ["10.1021/bi5000564", "PMC3985860", "24576155"]}, {"Citation": "Redgrave LS, Sutton SB, Webber MA, Piddock LJ. Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success. Trends Microbiol. 2014;22(8):438\u2013445. doi:10.1016/j.tim.2014.04.007", "ArticleIdList": ["10.1016/j.tim.2014.04.007", "24842194"]}, {"Citation": "Drlica K, Malik M, Kerns RJ, Zhao X. Quinolone-mediated bacterial death. Antimicrob Agents Chemother. 2008;52(2):385\u2013392. doi:10.1128/aac.01617-06", "ArticleIdList": ["10.1128/aac.01617-06", "PMC2224783", "17724149"]}, {"Citation": "Drlica K, Hiasa H, Kerns R, Malik M, Mustaev A, Zhao X. Quinolones: action and resistance updated. Curr Top Med Chem. 2009;9(11):981\u2013998. doi:10.2174/156802609789630947", "ArticleIdList": ["10.2174/156802609789630947", "PMC3182077", "19747119"]}, {"Citation": "F\u00e0brega A, Madurga S, Giralt E, Vila J. Mechanism of action of and resistance to quinolones. Microb Biotechnol. 2009;2(1):40\u201361. doi:10.1111/j.1751-7915.2008.00063.x", "ArticleIdList": ["10.1111/j.1751-7915.2008.00063.x", "PMC3815421", "21261881"]}, {"Citation": "Gutierrez A, Stokes JM, Matic I. Our evolving understanding of the mechanism of quinolones. Antibiotics (Basel). 2018;7(2):E32. doi:10.3390/antibiotics7020032", "ArticleIdList": ["10.3390/antibiotics7020032", "PMC6023003", "29642475"]}, {"Citation": "Aldred KJ, McPherson SA, Wang P, et al. Drug interactions with Bacillus anthracis topoisomerase IV: biochemical basis for quinolone action and resistance. Biochemistry. 2012;51(1):370\u2013381. doi:10.1021/bi2013905", "ArticleIdList": ["10.1021/bi2013905", "PMC3261753", "22126453"]}, {"Citation": "Aldred KJ, McPherson SA, CLJr T, Kerns RJ, Osheroff N. Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge: mechanistic basis of quinolone resistance. Nucleic Acids Res. 2013;41(8):4628\u20134639. doi:10.1093/nar/gkt124", "ArticleIdList": ["10.1093/nar/gkt124", "PMC3632122", "23460203"]}, {"Citation": "Ruiz J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother. 2003;51(5):1109\u20131117. doi:10.1093/jac/dkg222", "ArticleIdList": ["10.1093/jac/dkg222", "12697644"]}, {"Citation": "Ruiz J. Transferable mechanisms of quinolone resistance from 1998 onward. Clin Microbiol Rev. 2019;32(4):e00007\u2013e00019. doi:10.1128/CMR.00007-19", "ArticleIdList": ["10.1128/CMR.00007-19", "PMC6730498", "31413045"]}, {"Citation": "Wohlkonig A, Chan PF, Fosberry AP, et al. Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance. Nat Struct Mol Biol. 2010;17(9):1152\u20131153. doi:10.1038/nsmb.1892", "ArticleIdList": ["10.1038/nsmb.1892", "20802486"]}, {"Citation": "Piddock LJ. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev. 2006;19(2):382\u2013402. doi:10.1128/CMR.19.2.382-402.2006", "ArticleIdList": ["10.1128/CMR.19.2.382-402.2006", "PMC1471989", "16614254"]}, {"Citation": "Poole K. Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria. Antimicrob Agents Chemother. 2000;44(9):2233\u20132241. doi:10.1128/aac.44.9.2233-2241.2000", "ArticleIdList": ["10.1128/aac.44.9.2233-2241.2000", "PMC90051", "10952561"]}, {"Citation": "S\u00e1enz Y, Ruiz J, Zarazaga M, Teixid\u00f3 M, Torres C, Vila J. Effect of the efflux pump inhibitor Phe-Arg-beta-naphthylamide on the MIC values of the quinolones, tetracycline and chloramphenicol, in Escherichia coli isolates of different origin. J Antimicrob Chemother. 2004;53(3):544\u2013545. doi:10.1093/jac/dkh117", "ArticleIdList": ["10.1093/jac/dkh117", "14762057"]}, {"Citation": "Guan X, Xue X, Liu Y, et al. Plasmid-mediated quinolone resistance\u2013current knowledge and future perspectives. J Int Med Res. 2013;41(1):20\u201330. doi:10.1177/0300060513475965", "ArticleIdList": ["10.1177/0300060513475965", "23569126"]}, {"Citation": "Jacoby GA, Strahilevitz J, Hooper DC. Plasmid-mediated quinolone resistance. Microbiol Spectr. 2014;2(5):1\u201324. doi:10.1128/microbiolspec.PLAS-0006-2013", "ArticleIdList": ["10.1128/microbiolspec.PLAS-0006-2013", "PMC4288778", "25584197"]}, {"Citation": "Mart\u00ednez-Mart\u00ednez L, Eliecer Cano M, Manuel Rodr\u00edguez-Mart\u00ednez J, Calvo J, Pascual A. Plasmid-mediated quinolone resistance. Expert Rev Anti Infect Ther. 2008;6(5):685\u2013711. doi:10.1586/14787210.6.5.685.", "ArticleIdList": ["10.1586/14787210.6.5.685", "18847406"]}, {"Citation": "Poirel L, Cattoir V, Nordmann P. Plasmid-mediated quinolone resistance; interactions between human, animal, and environmental ecologies. Front Microbiol. 2012;3:24. doi:10.3389/fmicb.2012.00024", "ArticleIdList": ["10.3389/fmicb.2012.00024", "PMC3270319", "22347217"]}, {"Citation": "Robicsek A, Jacoby GA, Hooper DC. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis. 2006;6(10):629\u2013640. doi:10.1016/S1473-3099(06)70599-0", "ArticleIdList": ["10.1016/S1473-3099(06)70599-0", "17008172"]}, {"Citation": "Rodr\u00edguez-Mart\u00ednez JM, Machuca J, Cano ME, Calvo J, Mart\u00ednez-Mart\u00ednez L, Pascual A. Plasmid-mediated quinolone resistance: two decades on. Drug Resist Updat. 2016;29:13\u201329. doi:10.1016/j.drup.2016.09.001", "ArticleIdList": ["10.1016/j.drup.2016.09.001", "27912841"]}, {"Citation": "Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev. 2009;22(4):664\u2013689. doi:10.1128/CMR.00016-09", "ArticleIdList": ["10.1128/CMR.00016-09", "PMC2772364", "19822894"]}, {"Citation": "Yanat B, Rodr\u00edguez-Mart\u00ednez JM, Touati A. Plasmid-mediated quinolone resistance in Enterobacteriaceae: a systematic review with a focus on Mediterranean countries. Eur J Clin Microbiol Infect Dis. 2017;36(3):421\u2013435. doi:10.1007/s10096-016-2847-x", "ArticleIdList": ["10.1007/s10096-016-2847-x", "27889879"]}, {"Citation": "Ovia\u00f1o M, Rodr\u00edguez-Mart\u00ednez JM, Pascual \u00c1, Bou G. Rapid detection of the plasmid-mediated quinolone resistance determinant AAC(6\u02b9)-Ib-cr in Enterobacteriaceae by MALDI-TOF MS analysis. J Antimicrob Chemother. 2017;72(4):1074\u20131080. doi:10.1093/jac/dkw552", "ArticleIdList": ["10.1093/jac/dkw552", "28065892"]}, {"Citation": "Abd El-Aziz NK, Gharib AA. Coexistence of plasmid-mediated quinolone resistance determinants and AmpC-Beta-Lactamases in Escherichia coli strains in Egypt. Cell Mol Biol (Noisy-Le-Grand). 2015;61(5):29\u201335. doi:10.14715/cmb/2015.61.5.5", "ArticleIdList": ["10.14715/cmb/2015.61.5.5", "26475385"]}, {"Citation": "Briales A, Rodr\u00edguez-Mart\u00ednez JM, Velasco C, et al. Prevalence of plasmid-mediated quinolone resistance determinants qnr and aac(6\u02b9)-Ib-cr in Escherichia coli and Klebsiella pneumoniae producing extended-spectrum \u03b2-lactamases in Spain. Int J Antimicrob Agents. 2012;39(5):431\u2013434. doi:10.1016/j.ijantimicag.2011.12.009", "ArticleIdList": ["10.1016/j.ijantimicag.2011.12.009", "22365240"]}, {"Citation": "Machuca J, Ag\u00fcero J, Mir\u00f3 E, et al. Prevalence of quinolone resistance mechanisms in Enterobacteriaceae producing acquired AmpC \u03b2-lactamases and/or carbapenemases in Spain. Enferm Infecc Microbiol Clin. 2017;35(8):487\u2013492. doi:10.1016/j.eimc.2016.05.006", "ArticleIdList": ["10.1016/j.eimc.2016.05.006", "27345951"]}, {"Citation": "Wang M, Tran JH, Jacoby GA, Zhang Y, Wang F, Hooper DC. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother. 2003;47(7):2242\u20132248. doi:10.1128/aac.47.7.2242-2248", "ArticleIdList": ["10.1128/aac.47.7.2242-2248", "PMC161834", "12821475"]}, {"Citation": "Nordmann P, Poirel L. Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J Antimicrob Chemother. 2005;56(3):463\u2013469. doi:10.1093/jac/dki245", "ArticleIdList": ["10.1093/jac/dki245", "16020539"]}, {"Citation": "Guillard T, Cambau E, Chau F, Massias L, de Champs C, Fantin B. Ciprofloxacin treatment failure in a murine model of pyelonephritis due to an AAC(6\u02b9)-Ib-cr-producing Escherichia coli strain susceptible to ciprofloxacin in vitro. Antimicrob Agents Chemother. 2013;57(12):5830\u20135835. doi:10.1128/AAC.01489-13", "ArticleIdList": ["10.1128/AAC.01489-13", "PMC3837926", "24018262"]}, {"Citation": "Robicsek A, Strahilevitz J, Jacoby GA, et al. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med. 2006;12(1):83\u201388. doi:10.1038/nm1347", "ArticleIdList": ["10.1038/nm1347", "16369542"]}, {"Citation": "Cattoir V, Poirel L, Nordmann P. Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France. Antimicrob Agents Chemother. 2008;52(10):3801\u20133804. doi:10.1128/AAC.00638-08", "ArticleIdList": ["10.1128/AAC.00638-08", "PMC2565908", "18644958"]}, {"Citation": "Kim HB, Wang M, Park CH, Kim EC, Jacoby GA, Hooper DC. oqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae. Antimicrob Agents Chemother. 2009;53(8):3582\u20133584. doi:10.1128/AAC.01574-08", "ArticleIdList": ["10.1128/AAC.01574-08", "PMC2715617", "19528276"]}, {"Citation": "Yamane K, Wachino J, Suzuki S, et al. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob Agents Chemother. 2007;51(9):3354\u20133360. doi:10.1128/AAC.00339-07", "ArticleIdList": ["10.1128/AAC.00339-07", "PMC2043241", "17548499"]}, {"Citation": "Ch\u00e1vez-Jacobo VM, Hern\u00e1ndez-Ram\u00edrez KC, Romo-Rodr\u00edguez P, et al. CrpP is a novel ciprofloxacin-modifying enzyme encoded by the Pseudomonas aeruginosa pUM505 plasmid. Antimicrob Agents Chemother. 2018;62(6):e02629\u2013e026217. doi:10.1128/AAC.02629-17", "ArticleIdList": ["10.1128/AAC.02629-17", "PMC5971611", "29581123"]}, {"Citation": "Ch\u00e1vez-Jacobo VM, Hern\u00e1ndez-Ram\u00edrez KC, Silva-S\u00e1nchez J, et al. Prevalence of the crpP gene conferring decreased ciprofloxacin susceptibility in enterobacterial clinical isolates from Mexican hospitals. J Antimicrob Chemother. 2019;74(5):1253\u20131259. doi:10.1093/jac/dky562", "ArticleIdList": ["10.1093/jac/dky562", "30753471"]}, {"Citation": "Tav\u00edo MM, Jacoby GA, Hooper DC. QnrS1 structure-activity relationships. J Antimicrob Chemother. 2014;69(8):2102\u20132109. doi:10.1093/jac/dku102", "ArticleIdList": ["10.1093/jac/dku102", "PMC4100707", "24729602"]}, {"Citation": "Jacoby GA, Corcoran MA, Mills DM, Griffin CM, Hooper DC. Mutational analysis of quinolone resistance protein QnrB1. Antimicrob Agents Chemother. 2013;57(11):5733\u20135736. doi:10.1128/AAC.01533-13", "ArticleIdList": ["10.1128/AAC.01533-13", "PMC3811324", "23979738"]}, {"Citation": "Tran JH, Jacoby GA, Hooper DC. Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase. Antimicrob Agents Chemother. 2005;49(1):118\u2013125. doi:10.1128/AAC.49.1.118-125.2005", "ArticleIdList": ["10.1128/AAC.49.1.118-125.2005", "PMC538914", "15616284"]}, {"Citation": "Tran JH, Jacoby GA, Hooper DC. Interaction of the plasmid-encoded quinolone resistance protein QnrA with Escherichia coli topoisomerase IV. Antimicrob Agents Chemother. 2005;49(7):3050\u20133052. doi:10.1128/AAC.49.7.3050-3052.2005", "ArticleIdList": ["10.1128/AAC.49.7.3050-3052.2005", "PMC1168640", "15980397"]}, {"Citation": "Vetting MW, Hegde SS, Wang M, Jacoby GA, Hooper DC, Blanchard JS. Structure of QnrB1, a plasmid-mediated fluoroquinolone resistance factor. J Biol Chem. 2011;286(28):25265\u201325273. doi:10.1074/jbc.M111.226936", "ArticleIdList": ["10.1074/jbc.M111.226936", "PMC3137097", "21597116"]}, {"Citation": "Hata M, Suzuki M, Matsumoto M, et al. Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrob Agents Chemother. 2005;49(2):801\u2013803. doi:10.1128/AAC.49.2.801-803.2005", "ArticleIdList": ["10.1128/AAC.49.2.801-803.2005", "PMC547361", "15673773"]}, {"Citation": "Pu XY, Pan JC, Wang HQ, Zhang W, Huang ZC, Gu YM. Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China. J Antimicrob Chemother. 2009;63(5):917\u2013920. doi:10.1093/jac/dkp087", "ArticleIdList": ["10.1093/jac/dkp087", "19297378"]}, {"Citation": "Pu XY, Pan JC, Gu YM, Zheng W, Li J, Yu H. Complete sequences and characterization of two novel plasmids carrying aac(6\u02b9)-Ib-cr and qnrS gene in Shigella flexneri. Microb Drug Resist. 2016;22(2):115\u2013122. doi:10.1089/mdr.2015.0082", "ArticleIdList": ["10.1089/mdr.2015.0082", "26469217"]}, {"Citation": "Ho YJ, Lu JW, Huang YL, Lai ZZ. Palmatine inhibits Zika virus infection by disrupting virus binding, entry, and stability. Biochem Biophys Res Commun. 2019;518(4):732\u2013738. doi:10.1016/j.bbrc.2019.08.120", "ArticleIdList": ["10.1016/j.bbrc.2019.08.120", "31472967"]}, {"Citation": "Long J, Song J, Zhong L, Liao Y, Liu L, Li X. Palmatine: a review of its pharmacology, toxicity and pharmacokinetics. Biochimie. 2019;162:176\u2013184. doi:10.1016/j.biochi.2019.04.008", "ArticleIdList": ["10.1016/j.biochi.2019.04.008", "31051209"]}, {"Citation": "Clinical and Laboratory Standards Institute (CLSI). Methods for dilution of antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-10th edition. CLSI Document M07-A10. Wayne (PA): Clinical and Laboratory Standards Institute; 2015."}, {"Citation": "Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; 25th informational supplement. CLSI Document M100-S25. Wayne (PA): Clinical and Laboratory Standards Institute; 2015"}, {"Citation": "Teng Z, Guo Y, Liu X, et al. Theaflavin-3,3\u00b4-digallate increases the antibacterial activity of \u03b2-lactam antibiotics by inhibiting metallo-\u03b2-lactamase activity. J Cell Mol Med. 2019;23(10):6955\u20136964. doi:10.1111/jcmm.14580", "ArticleIdList": ["10.1111/jcmm.14580", "PMC6787515", "31392792"]}, {"Citation": "Zhou Y, Wang J, Guo Y, et al. Discovery of a potential MCR-1 inhibitor that reverses polymyxin activity against clinical mcr-1-positive Enterobacteriaceae. J Infect. 2019;78(5):364\u2013372. doi:10.1016/j.jinf.2019.03.004", "ArticleIdList": ["10.1016/j.jinf.2019.03.004", "30851289"]}, {"Citation": "Zhu L, Kalimuthu S, Gangadaran P, et al. Exosomes derived from natural killer cells exert therapeutic effect in melanoma. Theranostics. 2017;7(10):2732\u20132745. doi:10.7150/thno.18752", "ArticleIdList": ["10.7150/thno.18752", "PMC5558565", "28819459"]}, {"Citation": "Ma Z, Qu B, Zhong S, Yao L, Gao Z, Zhang S. Subtle difference generates big dissimilarity: comparison of enzymatic activity in KL1 and KL2 domains of lancelet klotho. Mar Biotechnol (NY). 2019;21(4):448\u2013462. doi:10.1007/s10126-019-09891-0", "ArticleIdList": ["10.1007/s10126-019-09891-0", "31053952"]}, {"Citation": "Wallace AC, Laskowski RA, Thornton JM. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 1995;8(2):127\u2013134. doi:10.1093/protein/8.2.127", "ArticleIdList": ["10.1093/protein/8.2.127", "7630882"]}, {"Citation": "Carattoli A. Plasmids and the spread of resistance. Int J Med Microbiol. 2013;303(6\u20137):298\u2013304. doi:10.1016/j.ijmm.2013.02.001", "ArticleIdList": ["10.1016/j.ijmm.2013.02.001", "23499304"]}, {"Citation": "Flach CF, Boulund F, Kristiansson E, Larsson DJ. Functional verification of computationally predicted qnr genes. Ann Clin Microbiol Antimicrob. 2013;12:34. doi:10.1186/1476-0711-12-34", "ArticleIdList": ["10.1186/1476-0711-12-34", "PMC4222258", "24257207"]}, {"Citation": "Machuca J, Briales A, Labrador G, et al. Interplay between plasmid-mediated and chromosomal-mediated fluoroquinolone resistance and bacterial fitness in Escherichia coli. J Antimicrob Chemother. 2014;69(12):3203\u20133215. doi:10.1093/jac/dku308", "ArticleIdList": ["10.1093/jac/dku308", "25139837"]}, {"Citation": "Paiva MC, Reis MP, Costa PS, et al. Identification of new bacteria harboring qnrS and aac(6\u02b9)-Ib/cr and mutations possibly involved in fluoroquinolone resistance in raw sewage and activated sludge samples from a full-scale WWTP. Water Res. 2017;110:27\u201337. doi:10.1016/j.watres.2016.11.056", "ArticleIdList": ["10.1016/j.watres.2016.11.056", "27984803"]}, {"Citation": "Pu XY, Gu Y, Li J, Song SJ, Lu Z. Characterization of the complete sequences and stability of plasmids carrying the genes aac(6\u02b9)-Ib-cr or qnrS in Shigella flexneri in the Hangzhou area of China. World J Microbiol Biotechnol. 2018;34(6):72. doi:10.1007/s11274-018-2454-3", "ArticleIdList": ["10.1007/s11274-018-2454-3", "29777316"]}, {"Citation": "Liu S, Zhou Y, Niu X, et al. Magnolol restores the activity of meropenem against NDM-1-producing Escherichia coli by inhibiting the activity of metallo-beta-lactamase. Cell Death Discov. 2018;4:28. doi:10.1038/s41420-018-0029-6", "ArticleIdList": ["10.1038/s41420-018-0029-6", "PMC5841300", "29531825"]}, {"Citation": "Wang L, Li B, Si X, et al. Quercetin protects rats from catheter-related Staphylococcus aureus infections by inhibiting coagulase activity. J Cell Mol Med. 2019;23(7):4808\u20134818. doi:10.1111/jcmm.14371", "ArticleIdList": ["10.1111/jcmm.14371", "PMC6584481", "31094081"]}, {"Citation": "Zhou Y, Liu S, Wang T, et al. Pterostilbene, a potential MCR-1 inhibitor that enhances the efficacy of polymyxin B. Antimicrob Agents Chemother. 2018;62(4):e02146\u2013e021417. doi:10.1128/AAC.02146-17", "ArticleIdList": ["10.1128/AAC.02146-17", "PMC5913934", "29339386"]}, {"Citation": "Maurice F, Broutin I, Podglajen I, Benas P, Collatz E, Dardel F. Enzyme structural plasticity and the emergence of broad-spectrum antibiotic resistance. EMBO Rep. 2008;9(4):344\u2013349. doi:10.1038/embor.2008.9", "ArticleIdList": ["10.1038/embor.2008.9", "PMC2288771", "18292754"]}, {"Citation": "Vetting MW, Park CH, Hegde SS, Jacoby GA, Hooper DC, Blanchard JS. Mechanistic and structural analysis of aminoglycoside N-acetyltransferase AAC(6\u02b9)-Ib and its bifunctional, fluoroquinolone-active AAC(6\u02b9)-Ib-cr variant. Biochemistry. 2008;47(37):9825\u20139835. doi:10.1021/bi800664x", "ArticleIdList": ["10.1021/bi800664x", "PMC2855648", "18710261"]}]}], "History": [{"Year": "2019", "Month": "12", "Day": "13"}, {"Year": "2020", "Month": "2", "Day": "13"}, {"Year": "2020", "Month": "3", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "3", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "3", "Day": "27", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "3", "Day": "9"}], "PublicationStatus": "epublish", "ArticleIdList": ["32210589", "PMC7069587", "10.2147/IDR.S242304", "242304"]}}]}